ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $619.18 million. The enterprise value is $411.00 million.

Market Cap	619.18M
Enterprise Value	411.00M

Important Dates

The next estimated earnings date is Monday, May 6, 2024, after market close.

Earnings Date	May 6, 2024
Ex-Dividend Date	n/a

Share Statistics

ORIC has 67.38 million shares outstanding. The number of shares has increased by 29.75% in one year.

Shares Outstanding	67.38M
Shares Change (YoY)	+29.75%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	9.53%
Owned by Institutions (%)	88.44%
Float	37.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.76
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.39, with zero debt.

Current Ratio	10.39
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.70% and return on invested capital (ROIC) is -49.44%.

Return on Equity (ROE)	-42.70%
Return on Assets (ROA)	-38.60%
Return on Capital (ROIC)	-49.44%
Revenue Per Employee	n/a
Profits Per Employee	-$1.01M
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.59% in the last 52 weeks. The beta is 1.03, so ORIC's price volatility has been similar to the market average.

Beta (1Y)	1.03
52-Week Price Change	+65.59%
50-Day Moving Average	12.44
200-Day Moving Average	9.19
Relative Strength Index (RSI)	25.08
Average Volume (30 Days)	570,653

Short Selling Information

The latest short interest is 8.14 million, so 12.08% of the outstanding shares have been sold short.

Short Interest	8.14M
Short Previous Month	6.93M
Short % of Shares Out	12.08%
Short % of Float	21.95%
Short Ratio (days to cover)	10.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-110.78M
Pretax Income	-100.70M
Net Income	-100.70M
EBITDA	-99.67M
EBIT	-100.70M
Earnings Per Share (EPS)	-$1.96

Full Income Statement

Balance Sheet

The company has $208.19 million in cash and no debt, giving a net cash position of $208.19 million or $3.09 per share.

Cash & Cash Equivalents	208.19M
Total Debt	n/a
Net Cash	208.19M
Net Cash Per Share	$3.09
Equity / Book Value	224.09M
Book Value Per Share	3.33
Working Capital	192.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$85.69 million and capital expenditures -$849,000, giving a free cash flow of -$86.54 million.

Operating Cash Flow	-85.69M
Capital Expenditures	-849,000
Free Cash Flow	-86.54M
FCF Per Share	-$1.68

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.75%
Shareholder Yield	-29.75%
Earnings Yield	-16.26%
FCF Yield	-13.98%

Analyst Forecast

The average price target for ORIC is $21.33, which is 132.10% higher than the current price. The consensus rating is "Buy".

Price Target	$21.33
Price Target Difference	132.10%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1